Rab 37 activators can include various chemicals that modulate cellular processes and signaling pathways interconnected with vesicle trafficking and membrane dynamics. GTPγS, as a non-hydrolysable GTP analogue, can sustain GTPases like Rab 37 in an active state by inhibiting GTP hydrolysis. This mechanism ensures prolonged activity of Rab 37, necessary for its role in vesicle movement. Compounds like PIP2 directly affect the localization and membrane association of Rab GTPases, ensuring that Rab 37 is recruited to the appropriate membrane sites to exert its function. In contrast, Brefeldin A alters the vesicle trafficking machinery by disrupting other small GTPases or vesicle formation, which could lead to a compensatory increase in Rab 37 activity as the cell attempts to restore homeostasis.
Other compounds like Forskolin and Ionomycin act by altering intracellular signaling molecules-cAMP and calcium, respectively. These changes can have downstream effects on membrane trafficking pathways, thereby impacting Rab 37 activity. Agents such as Monensin, Okadaic Acid, and Nitric Oxide Donors modulate the intracellular environment and signaling cascades, leading to indirect effects on Rab 37 function by altering the broader landscape of vesicular transport. Compounds like Methyl-β-cyclodextrin and Neomycin change membrane composition and fluidity, which can influence the overall trafficking machinery that Rab 37 is a part of. Lastly, Cytochalasin D's role in cytoskeletal dynamics showcases the interconnected nature of the cell's structural components with membrane trafficking processes where Rab 37 is a critical player.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $456.00 | ||
A non-hydrolysable analogue of GTP that can activate GTPases by preventing the GTP hydrolysis step, potentially maintaining Rab 37 in its active, GTP-bound state. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
An inhibitor of ADP-ribosylation factor (Arf), which modulates vesicle formation. By disrupting Arf, Brefeldin A can cause a build-up of vesicular membranes, potentially indirectly increasing Rab 37 activity as a compensatory mechanism. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
An activator of adenylate cyclase, increasing cAMP levels, which can modulate vesicular trafficking and potentially enhance Rab 37-related pathways. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
A Na+/H+ ionophore that alters intracellular pH and sodium concentrations, influencing vesicle formation and trafficking, possibly affecting Rab 37 activity indirectly. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, leading to altered phosphorylation states of proteins involved in membrane trafficking, which could indirectly enhance Rab 37 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
A calcium ionophore that elevates intracellular calcium levels, potentially influencing vesicle fusion and Rab 37 activity as calcium is a critical secondary messenger in vesicle dynamics. | ||||||
2-Hydroxypropyl-β-cyclodextrin | 128446-35-5 | sc-203461 sc-203461B sc-203461C sc-203461A | 1 g 100 g 500 g 5 g | $52.00 $620.00 $1950.00 $130.00 | 8 | |
Extracts cholesterol from membranes, altering membrane fluidity, and potentially affecting the membrane trafficking pathways involving Rab 37. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $26.00 $34.00 | 20 | |
An aminoglycoside antibiotic that binds to phosphoinositides, potentially affecting Rab GTPase localization and function, which may alter Rab 37 activity. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
An inhibitor of actin polymerization, which can disrupt cytoskeletal dynamics and consequently influence vesicular trafficking, potentially affecting Rab 37's role in this process. | ||||||